Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization

Author(s):  
Ali Ezzat ◽  
Peilin Zhao ◽  
Min Wu ◽  
Xiao-Li Li ◽  
Chee-Keong Kwoh
2016 ◽  
Vol 12 (2) ◽  
pp. e1004760 ◽  
Author(s):  
Yong Liu ◽  
Min Wu ◽  
Chunyan Miao ◽  
Peilin Zhao ◽  
Xiao-Li Li

2021 ◽  
Author(s):  
Yihua Ye ◽  
Yuxin Chen ◽  
Zhongnan Zhang ◽  
Yuqi Wen ◽  
Song He ◽  
...  

2019 ◽  
Author(s):  
Aanchal Mongia ◽  
Angshul Majumdar

AbstractDrug discovery is an important field in the pharmaceutical industry with one of its crucial chemogenomic process being drug-target interaction prediction. This interaction determination is expensive and laborious, which brings the need for alternative computational approaches which could help reduce the search space for biological experiments. This paper proposes a novel framework for drug-target interaction (DTI) prediction: Multi-Graph Regularized Deep Matrix Factorization (MGRDMF). The proposed method, motivated by the success of deep learning, finds a low-rank solution which is structured by the proximities of drugs and targets (drug similarities and target similarities) using deep matrix factorization. Deep matrix factorization is capable of learning deep representations of drugs and targets for interaction prediction. It is an established fact that drug and target similarities incorporation preserves the local geometries of the data in original space and learns the data manifold better. However, there is no literature on which the type of similarity matrix (apart from the standard biological chemical structure similarity for drugs and genomic sequence similarity for targets) could best help in DTI prediction. Therefore, we attempt to take into account various types of similarities between drugs/targets as multiple graph Laplacian regularization terms which take into account the neighborhood information between drugs/targets. This is the first work which has leveraged multiple similarity/neighborhood information into the deep learning framework for drug-target interaction prediction. The cross-validation results on four benchmark data sets validate the efficacy of the proposed algorithm by outperforming shallow state-of-the-art computational methods on the grounds of AUPR and AUC.


2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Aizhen Wang ◽  
Minhui Wang

Drug-target interactions provide useful information for biomedical drug discovery as well as drug development. However, it is costly and time consuming to find drug-target interactions by experimental methods. As a result, developing computational approaches for this task is necessary and has practical significance. In this study, we establish a novel dual Laplacian graph regularized logistic matrix factorization model for drug-target interaction prediction, referred to as DLGrLMF briefly. Specifically, DLGrLMF regards the task of drug-target interaction prediction as a weighted logistic matrix factorization problem, in which the experimentally validated interactions are allocated with larger weights. Meanwhile, by considering that drugs with similar chemical structure should have interactions with similar targets and targets with similar genomic sequence similarity should in turn have interactions with similar drugs, the drug pairwise chemical structure similarities as well as the target pairwise genomic sequence similarities are fully exploited to serve the matrix factorization problem by using a dual Laplacian graph regularization term. In addition, we design a gradient descent algorithm to solve the resultant optimization problem. Finally, the efficacy of DLGrLMF is validated on various benchmark datasets and the experimental results demonstrate that DLGrLMF performs better than other state-of-the-art methods. Case studies are also conducted to validate that DLGrLMF can successfully predict most of the experimental validated drug-target interactions.


Sign in / Sign up

Export Citation Format

Share Document